Urinary chiro-Inositol Excretion is an Index Marker of Insulin Sensitivity in Japanese Type II Diabetes

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Diabetes Care

• Publication date

  1994-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diacare.17.12.1465PMID 7882818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Office Guide to Diagnosis and Classification of Diabetes Mellitus and Other Categories of Glucose Intolerance

  1995cited by this paper
• Effect of a sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose-mediated glucose disposal in patients with non-insulin-dependent diabetes mellitus (NIDDM).

  1993cited by this paper
• Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys.

  1993cited by this paper
• chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.

  1993cited by this paper
• Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor.

  1993cited by this paper
• Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys.

  1993cited by this paper
• Pathogenesis of NIDDM: A Balanced Overview

  1992cited by this paper
• In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.

  1992cited by this paper
• Pathogenic Factors Responsible for Glucose Intolerance in Patients With NIDDM

  1992cited by this paper
• Insulin Resistance in Skeletal Muscles in Patients With NIDDM

  1992cited by this paper
• The role of glycosyl-phosphoinositides in hormone action

  1991cited by this paper
• Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.

  1990cited by this paper
• Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects.

  1990cited by this paper
• Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach

  1989cited by this paper
• Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach.

  1989cited by this paper
• Insulin-Signaling Mechanisms: Lessons From the Old Testament of Glycogen Metabolism and the New Testament of Molecular Biology

  1988cited by this paper
• Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol.

  1988cited by this paper
• Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase.

  1986cited by this paper

• Imbalance of Myoinositol and D‐Chiro‐Inositol in Saliva of Children With Type‐1 Diabetes Mellitus: A Cross‐Sectional Study

  2024cites this paper
• Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes.

  2023cites this paper
• Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial

  2022cites this paper
• Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes

  2022cites this paper
• Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond

  2020cites this paper
• Placental Inositol Reduced in Gestational Diabetes as Glucose alters Inositol Transporters and IMPA1 enzyme expression.

  2020cites this paper
• A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy

  2020cites this paper
• Plasma and urinary inositol isomer profiles measured by UHPLC-MS/MS reveal differences in scyllo-inositol levels between non-pregnant and pregnant women

  2020cites this paper
• Effect of inositol and its derivatives on diabetes: a systematic review

  2019cites this paper
• Inositol and antioxidant supplementation: Safety and efficacy in pregnancy

  2019cites this paper
• d- chiro-Inositol Ameliorates High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance via PKCε-PI3K/AKT Pathway.

  2019cites this paper
• Metabolic fingerprinting of chorionic villous samples in normal pregnancy and chromosomal disorders

  2019cites this paper
• Inositols in Insulin Signaling and Glucose Metabolism

  2018cites this paper
• A pilot study of d-chiro-inositol plus folic acid in overweight patients with type 1 diabetes

  2017cites this paper
• A mio-inozitol jótékony hatása inzulint

  2017cites this paper
• Effects of inositol on glucose homeostasis: Systematic review and meta-analysis of randomized controlled trials.

  2017cites this paper
• Inositol(s) from Bench to Bedside in Endocrinology and Gynecology

  2017cites this paper
• Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols

  2017cites this paper
• Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders

  2017cites this paper
• [The myo-inositol is beneficial in the therapy of pregnancy with insulin-dependent type 2 diabetes and polycystic ovary syndrome].

  2017cites this paper
• Natural molecules for the therapy of hyperandrogenism and metabolic disorders in PCOS.

  2017cites this paper
• Putative Key Role of Inositol Messengers in Endothelial Cells in Preeclampsia

  2016cites this paper
• A review of prevention strategies for gestational diabetes: is there a missing X-factor?

  2016cites this paper
• Local manganese chloride treatment accelerates fracture healing in a rat model

  2015cites this paper
• The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study

  2015cites this paper
• Acid α-galactosidase is involved in D-chiro-inositol accumulation during tartary buckwheat germination

  2015cites this paper
• Inositol versus metformin administration in polycystic ovarian disease patients: a case–control study

  2015cites this paper
• Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.

  2015cites this paper
• Myo‐inositol for preventing gestational diabetes

  2015cites this paper
• Inositol versus Metformin administration in polycystic ovary syndrome patients: a case–control study

  2015cites this paper
• The Hypoglycemic Effect of Pumpkin Seeds, Trigonelline (TRG), Nicotinic Acid (NA), and D-Chiro-inositol (DCI) in Controlling Glycemic Levels in Diabetes Mellitus

  2014cites this paper
• Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls.

  2014cites this paper
• Inositol: history of an effective therapy for Polycystic Ovary Syndrome.

  2014cites this paper
• Medical management of clomiphene-resistant polycystic ovarian syndrome: an update -

  2014cites this paper
• Study of QSAR Descriptors of Antihyperglycemic Principle Pinitol Using Computation Servers

  2013cites this paper
• Molecular Docking Interaction of Pinitol (Ligand) with Dipeptidyl Peptidase-4 Receptor (PDB 3C45)

  2013cites this paper
• Urinary Chiro- and Myo-Inositol Levels as a Biological Marker for Type 2 Diabetes Mellitus

  2012influential citation
• The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes

  2011cites this paper
• d-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review

  2011cites this paper
• Application of Near-Infrared Reflectance Spectroscopy to the Evaluation of D-chiro-Inositol,Vitexin,and Isovitexin Contents in Mung Bean

  2011cites this paper
• Inositol phosphoglycans and preeclampsia: from bench to bedside.

  2011cites this paper
• Experimental model proposed to deduce pharmacological evidence of the beta-cell neogenesis activity of Argyrolobium roseum vis-a-vis an evaluation of its hypoglycemic activity

  2011cites this paper
• Contents of D-chiro-Inositol, Vitexin, and Isovitexin in Various Varieties of Mung Bean and Its Products

  2011cites this paper
• Effects of Pinitol on Glycemic Control, Insulin Resistance and Adipocytokine Levels in Patients with Type 2 Diabetes Mellitus

  2011cites this paper
• D-Chiro-Inositol Glycans in Insulin Signaling and Insulin Resistance

  2010cites this paper
• Synergistic Effects of d-Chiro-Inositol and Manganese on Blood Glucose and Body Weight of Streptozotocin-Induced Diabetic Rats

  2010cites this paper
• Uncoupling Between Insulin and Release of a d-Chiro-Inositol–Containing Inositolphosphoglycan Mediator of Insulin Action in Obese Women With Polycystic Ovary Syndrome

  2010cites this paper
• Characteristics of Pinitol as a Functional Food Biomaterial

  2009cites this paper
• Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity.

  2009cites this paper
• Involvement of Cdk Inhibitor p21(WIP1/CIP1) in G2/M Arrest of Human Myeloid Leukemia U937 Cells by N-Methyl-N'-Nitro-N-Nitrosoguanidine

  2009cites this paper
• The link between insulin resistance and preeclampsia: new perspectives.

  2009cites this paper
• Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation.

  2008cites this paper
• D-chiro-inositol-enriched tartary buckwheat bran extract lowers the blood glucose level in KK-Ay mice.

  2008cites this paper
• Antidiabetic activity of Mung bean extracts in diabetic KK-Ay mice.

  2008cites this paper
• Urinary excretion of inositol phosphoglycan P‐type in gestational diabetes mellitus

  2007cites this paper
• Evolution of the diverse biological roles of inositols.

  2007cites this paper
• Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies.

  2007cites this paper
• Phosphatidylinositol Synthase of Tetrahymena: Inositol Isomers as Substrates in Phosphatidylinositol Biosynthesis and Headgroup Exchange Reactions

  2007cites this paper
• Identifizierung und Quantifizierung von myo- und chiro- Inositol in Plasma und Erythrozyten von erstgradig Verwandten an Diabetes mellitus Typ 2 erkrankter Patienten

  2007cites this paper
• D-CHIRO-INOSITOL FOUND IN MOMORDICA CHARANTIA FRUIT EXTRACT PLAYS A ROLE IN REDUCING BLOOD GLUCOSE IN STREPTOZOTOCIN-DIABETIC RATS

  2007cites this paper
• Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide.

  2006cites this paper
• Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome.

  2006cites this paper
• Specific sensing between inositol epimers by a bis(boronate).

  2005cites this paper
• Determination of Urinary Myo-/Chiro-Inositol Ratios from Korean Diabetes Patients

  2005cites this paper
• Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

  2005cites this paper
• Effect of chiro-inositol from Soybean on Reducing Hyperglycemia and Its Role for Nutraceutic Supplement for Insulin Resistance

  2005cites this paper
• A Paradox: the roles of inositolphosphoglycans in mediating insulin sensitivity and hyperandrogenism in the polycystic ovary syndrome.

  2004cites this paper
• Urinary chiro-Inositol and myo-inositol Excretion is Elevated in the Diabetic db/db Mouse and Streptozotocin Diabetic Rat

  2003cites this paper
• Insulin-lowering agents in the management of polycystic ovary syndrome.

  2003cites this paper
• Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity.

  2003cites this paper
• Treatment of the adolescent patient with polycystic ovary syndrome.

  2003cites this paper
• D-Chiro-Inositol – Its Functional Role in Insulin Action and its Deficit in Insulin Resistance

  2002cites this paper
• D-chiro-inositol and Insulin Resistance: An Allosteric Point of View

  2002cites this paper
• Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.

  2002cites this paper
• Fasting Decreases the Content of D-Chiroinositol in Human Skeletal Muscle

  2002cites this paper
• Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome.

  2002cites this paper
• D‐Chiro‐Inositol in Insulin Action and Insulin Resistance ‐ Old‐Fashioned Biochemistry Still at Work

  2001cites this paper
• Use of insulin-sensitizing agents in patients with polycystic ovary syndrome.

  2001cites this paper
• HMR361 44__51

  2001cites this paper
• Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.

  2001cites this paper
• New treatments of hyperandrogenism and hirsutism.

  2000cites this paper
• Insulin‐like effect of pinitol

  2000cites this paper
• Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder.

  2000cites this paper
• Insulin-like e ect of pinitol

  2000cites this paper
• Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.

  1999cites this paper
• Identification of chiro-inositol-containing phospholipids and changes in their metabolism upon salt stress in soybean seedlings.

  1999cites this paper
• Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

  1999cites this paper
• Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.

  1999cites this paper
• Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes.

  1999cites this paper
• Phosphoinositol Glycan Derived Mediators and Insulin Resistance. Prospects for Diagnosis and Therapy

  1998cites this paper
• The role of glycosyl-phosphatidylinositol in signal transduction.

  1998cites this paper
• In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat.

  1998cites this paper
• In Vivo chiro-lnositol Metabolism in the Rat: A Defect in chiro-Inositol Synthesis from myo-lnositol and an Increased Incorporation of chiro-[3H]inositol into Phospholipid in the Goto-Kakizaki (G.K.) Rat

  1998cites this paper
• Isolation and partial characterisation of insulin-mimetic inositol phosphoglycans from human liver.

  1997cites this paper
• Inositols—Potential roles in insulin action and in diabetes: Evidence from insulin-resistant nonhuman primates

  1996cites this paper
• Urinary myo-Inositol-to-chiro-Inositol Ratios and Insulin Resistance

  1996cites this paper
• Dietary myoinositol results in lower urine glucose and in lower postprandial plasma glucose in obese insulin resistant rhesus monkeys.

  1996cites this paper
• Infusion of pH 2.0 d-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycaemia

  1996cites this paper
• Effect of manidipine and delapril on insulin sensitivity in type 2 diabetic patients with essential hypertension.

  1996cites this paper
• Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphatase.

  1996cites this paper